About
Boris Reznik is a biotech and longevity executive currently serving as Chairman and CEO of Immorta Bio and Chairman of Venvalo Group. Company and industry materials describe him as the founder and former leader of Biorasi, a clinical research organization, and as an advisor or board participant in regenerative-medicine and biotechnology companies. His public profile is strongest as an operator, strategist, and industry connector in longevity, biotech, and clinical development rather than as a documented fund manager or independently verified capital allocator.
Areas of interest
longevitybiotechregenerative medicineclinical trialsclinical developmentmedical devicesventure building